Sector: MedicalCelgene Corporation (NASDAQ: CELG)
Headlines
- Celgene Corporation to Present at Two Upcoming Investor Conferences
Nov 06, 2009 04:30 PM | CELG
- Neah Power CEO Appears on "Winning Strategies With Tim Connolly" Friday, Nov. 6, 2009, 10:00 a.m. EST
Nov 05, 2009 08:02 AM | CELG
- Celgene: Buy On A Pullback
Nov 04, 2009 01:09 PM | CELG
- Celgene Corporation to Present at the Oppenheimer & Co. Inc. 20th Annual Healthcare Conference
Oct 30, 2009 07:30 AM | CELG
- Neah Power CEO Will Appear on "Winning Strategies with Tim Connolly" on Oct. 30, 2009, 9:30 am ET
Oct 29, 2009 06:01 AM | CELG
- Celgene (CELG): Bet On biotech
Oct 21, 2009 01:47 PM | CELG
- Updated Data from Randomized Controlled Phase II Study Evaluating Oral Apremilast in Psoriatic Arthritis Demonstrates Sustained Response at Six Months
Oct 19, 2009 06:38 PM | CELG
- Celgene Corporation to Announce Third Quarter Results on October 22, 2009
Oct 13, 2009 04:30 PM | CELG
- Celgene Corporation (NASDAQ:CELG): Third Quarter Earnings Preview 2009
Oct 12, 2009 10:30 AM | CELG
- BUYINS.NET Issues Short Sale Report On MannKind
Oct 08, 2009 01:57 PM | AMGN, BIIB, CELG, GENZ, GILD
- Finding the Road to Riches
Oct 19, 2009 11:51 AM | CELG, SYY
- Lennar, Wal-Mart, Jack in the Box big movers
Sep 21, 2009 06:07 PM | CELG, DELL, GVA, OVTI, PER, POT
- Celgene Q2 Net Income Rises
Jul 24, 2009 11:00 AM | CELG
- Stocks Finish Mixed
Jun 18, 2009 11:00 AM | CELG, FDX, QCOM, USB, WFC
- Stocks: Finding Long-Term Winners
May 27, 2009 10:53 AM | CELG, CHRW, FLIR, GILD, MORN, SRCL
- Taking Stock: Nobody Wins for 2008
Jan 04, 2009 01:07 PM | AIG, ALK, AMZN, BA, BGG, CAT
- Investors Can Consider No-Risk, Low-Risk Options
Jan 04, 2009 07:11 AM | AIG, ALK, AMZN, AT, AXP, BA
- Health Care Poised to Weather Recession
Nov 02, 2008 10:54 AM | AMGN, ATK, BA, BAX, BDX, BIIB
- Health care, defense poised to weather recession
Nov 01, 2008 01:54 PM | AMGN, ATK, BA, BAX, BDX, BIIB
- Movers: AIG, Wal-Mart, Boeing, Ciena, Hovnanian
Sep 05, 2008 10:58 AM | AEO, AIG, ANF, BA, CELG, CIEN
- MethylGene Reports Third Quarter 2009 Financial Results
Nov 05, 2009 07:52 AM | CELG
- Celgene Reports Record Third Quarter 2009 Operating and Financial Results
Oct 22, 2009 07:51 AM | CELG, ENMD
- Lawsuit Claims Celgene Corporation Misappropriated the Idea Behind its Multiple Myeloma Treatments
Aug 25, 2009 10:54 AM | CELG
- GPC Biotech Reports Financial Results for Second Quarter and First Six Months of 2009
Aug 18, 2009 01:58 AM | CELG
- Clinical Data Evaluating Amrubicin® as Potential Therapy for Patients with Small Cell Lung Cancer Presented at 13th World Conference on Lung Cancer
Aug 05, 2009 07:46 AM | CELG
- VIDAZA Upgraded to Category 1 Based on Unprecedented Survival and Selected Preferred Treatment for Intermediate-2 and High-Risk Myelodysplastic Syndromes by the National Comprehensive Cancer Network (NCCN) in Its Clinical Practice Guidelines
Aug 05, 2009 07:34 AM | CELG
- Celgene Corporation to Present at Two Upcoming Investor Conferences
Aug 03, 2009 07:31 AM | CELG
- MethylGene Reports Second Quarter 2009 Financial Results
Jul 31, 2009 07:51 AM | CELG
- Celgene Reports Record Second Quarter 2009 Operating and Financial Results
Jul 23, 2009 07:34 AM | CELG
- Celgene Corporation to Announce Second Quarter Results on July 23, 2009
Jul 09, 2009 07:31 AM | CELG
- Form 4 CELGENE CORP /DE/ For: Oct 27 Filed by: Burton Graham (10K)
Oct 29, 2009 06:17 PM
- Form 4 GRYSKA DAVID W For: Oct 13 (10K)
Oct 15, 2009 06:22 PM
- Form 4 Burton Graham For: Oct 13 (10K)
Oct 15, 2009 06:18 PM
- Form 4 BARER SOL J For: Oct 13 (10K)
Oct 15, 2009 06:17 PM
- Form 4 HUGIN ROBERT J For: Oct 13 (10K)
Oct 15, 2009 06:16 PM
- Form 4 Van Hoek Andre For: Oct 13 (10K)
Oct 15, 2009 06:15 PM
- Form 4 HUGIN ROBERT J For: Oct 05 (10K)
Oct 07, 2009 06:30 PM
- Form 4 Van Hoek Andre For: Oct 01 (10K)
Oct 02, 2009 06:15 PM
- Form 4 BARER SOL J For: Sep 14 (10K)
Sep 16, 2009 05:44 PM
- Form 4 CELGENE CORP /DE/ For: Sep 04 Filed by: KAPLAN GILLA (10K)
Sep 09, 2009 06:14 PM
Analyst Ratings
Sentiment Survey
|
|
|
|
|
|
|
|
|
|
|
Share Performance
|
Period
|
CELG
|
Compare to S&P
|
| YTD |
-7.65 %
|
-19.50 %
|
| 4 Weeks |
-5.46 %
|
-6.46 %
|
| 12 Weeks |
-7.05 %
|
-9.35 %
|
|
Financial Ratios
Earnings Performance
|
EPS Growth in Last Quarter: 25.00 %
|
|
EPS Growth in Last Year: 47.06 %
|
|
Sales Growth in Last Quarter: 10.57 %
|
|
Sales Growth in Last Quarter: 17.33 %
|
|
